VIZIENT, INC. for VIZIENT INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Hospital Group Purchasing Organizations - Advocated for the importance of hospital GPOs, and highlighted role in securing essential, authentic medical supplies for hospitals throughout the course of the COVID-19 pandemic. Advocated for greater transparency in the health care supply chain for drugs and medical devices and greater transparency into the decision-making of the Strategic National Stockpile. COVID-19 Relief - H.R. 1319, The American Rescue Plan - Advocated for Congress to include provisions in COVID relief package to increase funding for the Provider Relief Fund. Urged robust support for vaccine distribution and administration. Supported inclusion of provisions that would provide liability protection for hospitals and health care workers, and provide for hazard pay for essential frontline health care workers. American Jobs Plan and Infrastructure - Monitored proposals from the American Jobs plan that would support investments in infrastructure for health care providers, including physical structure improvements and workforce and telehealth investments. Health Care Workforce - Urged passage of the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708; S. 168) Insurance Plans Limiting Distribution for Specialty Pharmaceuticals - Raised concerns about growing practice of "white bagging" where health plans prohibit hospitals from acquiring certain specialty pharmacy items to treat patients, and instead require purchase through a plan-affiliated specialty pharmacy. Unapproved Drugs Initiative - Engaged with HHS and the FDA to support modifications to the unapproved drugs initiative that would prevent or limit unintended price increases for older unapproved products. 340B Drug Pricing Program - Urged HHS to enforce guidance that would allow 340B Covered Entities to utilize contract pharmacies. Stark Law and Anti-kickback Statute - Encouraged Congress to continue evaluating Stark and Anti-kickback statutes to better enable care coordination in value-based alternative payment models.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
| JENNA STERN | — |
Medicare/Medicaid MMM
COVID-19 Relief - H.R. 1319, The American Rescue Plan - Advocated for flexibility in repayment for the Medicare Advanced and Accelerated Payment Program. Supported increasing the Medicaid Federal Medical Assistance Percentage (FMAP). Medicare Sequestration - Urged Congress to adopt legislation that would extend delay of implementation of Medicare and PayGo sequestration (H.R. 315; H.R. 1868) Health care Workforce - Supported legislation (S.834) to increase the number of Medicare-supported Graduate Medical Education (GME) slots and increase funding for Children's Hospital GME in FY2021. Rural Health Clinics - Supported legislation to correct Medicare reimbursement formula for rural health clinics (H.R. 1868; S. 934) Medicare Alternative Payment Models - Urged CMS and the Medicare Innovation Center to release more information on the Medicare Shared Savings Program and Direct Contracting models. Telehealth - Advocated for Congress to extend or make permanent flexibilities related to distant site and geographic limitations, expanding the provider types and services available to be reimbursed by Medicare.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
| JENNA STERN | — |
Tariff (miscellaneous tariff bills) TAR
Sec. 301 China Tariffs - Urged the U.S. Trade Representative to extend tariff exclusions for essential medical products needed to respond to the COVID-19 pandemic.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
| JENNA STERN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.